ECU
CERE

Eisler Capital (US)’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Eisler Capital (US)’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20,331
Closed -$831K – 706
2024
Q2 		$831K Buy
20,331
+3,432
+20% +$143K 0.01% 484
2024
Q1 		$714K Buy
+16,899
New +$710K 0.02% 432

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Eisler Capital (US)'s CERE Position: Q3 2024 in Review

Eisler Capital (US) sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 20,331 shares — an estimated $831K sold.

Eisler Capital (US) first reported a position in CERE in Q1 2024 and held it in 2 quarters. The position peaked at $831K in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Eisler Capital (US) reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Eisler Capital (US) sold 20,331 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $831K.
  • Eisler Capital (US) first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
  • Eisler Capital (US)'s Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $831K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Eisler Capital (US)'s 13F filing for Q3 2024, filed 14 Nov 2024.